Table 2.
Clinical characteristics of patients in the high- and low-risk groups from the training set.
Characteristics | High risk (N = 175) | Low risk (N = 175) | Total (N = 350) | p value | |
---|---|---|---|---|---|
Age | <65 | 78 | 72 | 150 | 0.5892 |
≥65 | 97 | 103 | 200 | ||
Stage | Stage I | 16 | 33 | 49 | 0.0106 |
Stage II | 59 | 52 | 111 | ||
Stage III | 76 | 79 | 155 | ||
Stage IV | 24 | 11 | 35 | ||
T | T1 | 3 | 13 | 16 | 0.0272 |
T2 | 43 | 31 | 74 | ||
T3 | 75 | 86 | 161 | ||
T4 | 50 | 45 | 95 | ||
Tx | 4 | 0 | 4 | ||
M | M0 | 150 | 162 | 312 | 0.1705 |
M1 | 15 | 8 | 23 | ||
Mx | 10 | 5 | 15 | ||
N | N0 | 41 | 63 | 104 | 0.0884 |
N1 | 50 | 43 | 93 | ||
N2 | 38 | 34 | 72 | ||
N3 | 40 | 31 | 71 | ||
Nx | 6 | 4 | 10 | ||
Gender | Female | 60 | 64 | 124 | 0.7374 |
Male | 115 | 111 | 226 | ||
Grade | G1 | 5 | 4 | 9 | 0.7498 |
G2 | 59 | 66 | 125 | ||
G3 | 106 | 101 | 207 | ||
Gx | 5 | 4 | 9 |